ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 202 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,440,000 | +7.7% | 40,000 | -20.0% | 0.73% | +125.1% |
| Q2 2019 | $1,337,000 | +84.9% | 50,000 | +5.6% | 0.32% | +16.2% |
| Q2 2018 | $723,000 | -63.1% | 47,351 | -27.2% | 0.28% | -61.7% |
| Q4 2017 | $1,957,000 | -56.7% | 65,000 | -45.8% | 0.73% | -52.8% |
| Q3 2017 | $4,520,000 | +194.7% | 120,000 | +118.2% | 1.54% | +174.2% |
| Q2 2017 | $1,534,000 | -31.4% | 55,000 | -15.4% | 0.56% | -46.1% |
| Q1 2017 | $2,235,000 | +10.7% | 65,000 | -7.1% | 1.04% | +8.1% |
| Q4 2016 | $2,019,000 | -3.2% | 70,000 | +6.7% | 0.96% | -8.5% |
| Q3 2016 | $2,086,000 | +11.8% | 65,577 | +14.0% | 1.05% | +13.4% |
| Q2 2016 | $1,866,000 | -33.3% | 57,500 | -42.5% | 0.93% | -25.0% |
| Q1 2016 | $2,796,000 | +30.7% | 100,000 | +66.7% | 1.24% | +21.9% |
| Q4 2015 | $2,139,000 | +14.9% | 60,000 | +6.5% | 1.02% | +12.5% |
| Q3 2015 | $1,862,000 | -11.1% | 56,314 | +12.6% | 0.90% | +24.2% |
| Q2 2015 | $2,094,000 | +83.5% | 50,000 | +42.9% | 0.73% | +87.4% |
| Q1 2015 | $1,141,000 | – | 35,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |